FULL TEST r1
TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCE
r1 r1 r1
r1
r1 r1
D PRACTICE A PRACTICAL APPROACH 5TH
r1 r1 r1 r1 r1
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
r1 r1 r1 r1 r1 r1
PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
r1 r1 r1 r1 r1
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
r1 r1 r1 r1 r1 r1 r1 r1 r1
VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
r1 r1 r1 r1 r1 r1 r1
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
r1 r 1 r1 r 1 r1 r 1
For more Test banks, ATI, HES! exams, and more contact us.
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
, Tableofcontent r1 1r
Chapter I Issues for the Practitioner in Drug Therapy
r1 r1 r1 r1 r1 r1 r1 r1
Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
r1 r1 r1 r1 r1 r1 r1 r1 r1
Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics Cha
r1 r 1 r1 r1 r1 r 1 r1 r1 r 1 r1 r1
pter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and Lactation Chap
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
ter 5 Pharmacotherapy Principles in Older Adults
r1 r1 r1 r1 r1 r1
Chapter 6 Principles of Antimicrobial Therapy Chapte
r1 r1 r1 r1 r1 r1
r 7 Pharmacogenomies
r1 r1
Chapter 8 The Economics of Pharmacotherapeutics C
r1 r1 r1 r1 r1 r1
hapter 9 Pharmacotherapy of Pain Management
r1 r1 r1 r1 r1
Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients C
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
hapter 11 Cannabis and Pain Management
r1 r1 r1 r1 r1
Chapter 12 Contact Dermatitis r1 r1 r1
Chapter 13 Fungal, Viral, and Bacterial Infections of the Skin C
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
hapter 14 Psoriasis r1 r1
Chapter I5 Acne Vulgaris and Rosacea Chapt
r1 r1 r1 r1 r1 r1
er 16 Ophthalmic Disorders
r1 r1 r1
Chapter I7 Otitis Media and Otitis Externa Ch
r1 r1 r1 r1 r1 r1 r1
apter I8 Hypertension r1 r1
Chapter I9 Hyperlipidemia r1 r1
Chapter 20 Chronic Stable Angina and Myocardial Infarction
r1 r1 r1 r1 r1 r1 r1 r1
Chapter 2I Heart Failure r1 r1 r1
Chapter 22 Arrhythmias r1 r1
Chapter 23 Respiratory Infections r1 r1 r1
Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease Chapt
r1 r1 r1 r1 r1 r1 r1 r1
er 25 Gastric, Functional, and Inflammatory Bowel Disorders Chapter
r1 r1 r1 r1 r1 r1 r1 r1 r1
26 Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chapter
r1 r1 r1 r1 r1 r1 r1 r1 r1
27 Liver Diseases
r1 r1
Chapter 28 Urinary Tract Infection r1 r1 r1 r1
Chapter 29 Prostatic Disorders and Erectile Dysfunction Chapt
r1 r1 r1 r1 r1 r1 r1
er 30 Overactive Bladder
r1 r1 r1
Chapter 3I Sexually Transmitted Infections
r1 r1 r1 r1 r
Chapter 32 Osteoarthritis and Gout Chapt
1 r1 r1 r1 r1 r1
er 33 Osteoporosis
r1 r1
Chapter 34 Rheumatoid Arthritis r1 r1 r1 r1
Chapter 35 Headaches r1 r1
Chapter 36 Seizure Disorders r1 r1 r1 r1
Chapter 37 Alzheimer's Disease r1 r1 r1 r 1
Chapter 38 Parkinson's Diseas r1 r1 r1
e
Chapter 39 Major Depressive Disorder and Bipolar Disorders
r1 r1 r1 r1 r1 r1 r1 r1
Chapter 40 Anxiety Disorders r1 r1 r1
Chapter 41 Sleep Disorders r1 r 1 r 1
Chapter 42 Attention Deficit Hyperactivity Disorder
r1 r1 r1 r1 r1 r1
Chapter 43 Substance Use Disorders r1 r1 r1 r1
Chapter 44 Diabetes Mellitus r1 r1 r1
Chapter 45 Thyroid and Parathyroid Disorders
r1 r1 r1 r1 r1
,Chapter 46 Allergies and Allergic Reactions
r1 r1 r1 r1 r1 r1
Chapter 47 Human Immunodeficiency Virus
r1 r1 r1 r1 r1
Chapter 48 Organ Transplantation
r1 r1 r1
Chapter 49 Thromboembolic Disorders Ch
r1 r1 r1 r1
apter 50 Anemias
r1 r1
Chapter 5l Immunizations Chap
r1 r1 r1
ter 52 Smoking Cessation Chapt
r1 r1 r1 r1
er 53 Weight Loss Chapter 54
r1 r1 r1 r1 r1 r1
Contraception
Chapter 55 Menopause
r1 r1
Chapter 56 Vaginitis
r1 r1
, r1 r
r1 r1
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
r1 r1 r1 r1 r1 r1 r1 r1
MULTIPLE CHOICE r1
1. Nurse practitioner prescriptive authority is regulated by:
r1 r1 r1 r1 r1 r1
A. The National Council of State Boards of Nursing
r1 r1 r1 r1 r1 r1 r1
B. The U.S. Drug Enforcement Administration
r1 r1 r1 r1
C. The State Board of Nursing for each state
r1 r1 r1 r1 r1 r1 r1
D. The State Board of Pharmacy
r1 r1 r1 r1
ANS: C r 1 PTS: r 1 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
r1 r1 r1 r1 r1 r1 r1
A. The National Council of State Boards of Nursing
r1 r1 r1 r1 r1 r1 r1
B. The U.S. Drug Enforcement Administration
r1 r1 r1 r1
C. The State Board of Nursing
r1 r1 r1 r1
D. The State Board of Medical Examiners
r1 r1 r1 r1 r1
ANS: D r 1 PTS: r 1 1
3. Clinical judgment in prescribing includes:
r1 r1 r1 r1
A. Factoring in the cost to the patient of the medication prescribed
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
B. Always prescribing the newest medication available for the disease process
r1 r1 r1 r1 r1 r1 r1 r1 r1
C. Handing out drug samples to poor patients
r1 r1 r1 r1 r1 r1
D. Prescribing all generic medications to cut costs r1 r1 r1 r1 r1 r1
ANS: A r 1 PTS: r 1 1
4. Criteria for choosing an effective drug for a disorder include:
r1 r1 r1 r1 r1 r1 r1 r1 r1
A. Asking the patient what drug they think would work best for them
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
B. Consulting nationally recognized guidelines for disease management
r1 r1 r1 r1 r1 r1
C. Prescribing medications that are available as samples before writing a prescription
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
r1 r1 r1 r1 r1 r1 r1 r1
prescribing
ANS: B r 1 PTS: r 1 1
5. Nurse practitioner practice may thrive under health-care reform due to:
r1 r1 r1 r1 r1 r1 r1 r1 r1
A. The demonstrated ability of nurse practitioners to control costs and improve patient
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1 r1 r
outcomes
1
B. The fact that nurse practitioners will be able to practice independently
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
C. The fact that nurse practitioners will have full reimbursement under health-
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
care reform r1
D. The ability to shift accountability for Medicaid to the state level
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
ANS: A r 1 PTS: r 1 1
TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCE
r1 r1 r1
r1
r1 r1
D PRACTICE A PRACTICAL APPROACH 5TH
r1 r1 r1 r1 r1
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
r1 r1 r1 r1 r1 r1
PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
r1 r1 r1 r1 r1
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
r1 r1 r1 r1 r1 r1 r1 r1 r1
VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
r1 r1 r1 r1 r1 r1 r1
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
r1 r 1 r1 r 1 r1 r 1
For more Test banks, ATI, HES! exams, and more contact us.
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
, Tableofcontent r1 1r
Chapter I Issues for the Practitioner in Drug Therapy
r1 r1 r1 r1 r1 r1 r1 r1
Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
r1 r1 r1 r1 r1 r1 r1 r1 r1
Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics Cha
r1 r 1 r1 r1 r1 r 1 r1 r1 r 1 r1 r1
pter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and Lactation Chap
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
ter 5 Pharmacotherapy Principles in Older Adults
r1 r1 r1 r1 r1 r1
Chapter 6 Principles of Antimicrobial Therapy Chapte
r1 r1 r1 r1 r1 r1
r 7 Pharmacogenomies
r1 r1
Chapter 8 The Economics of Pharmacotherapeutics C
r1 r1 r1 r1 r1 r1
hapter 9 Pharmacotherapy of Pain Management
r1 r1 r1 r1 r1
Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients C
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
hapter 11 Cannabis and Pain Management
r1 r1 r1 r1 r1
Chapter 12 Contact Dermatitis r1 r1 r1
Chapter 13 Fungal, Viral, and Bacterial Infections of the Skin C
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
hapter 14 Psoriasis r1 r1
Chapter I5 Acne Vulgaris and Rosacea Chapt
r1 r1 r1 r1 r1 r1
er 16 Ophthalmic Disorders
r1 r1 r1
Chapter I7 Otitis Media and Otitis Externa Ch
r1 r1 r1 r1 r1 r1 r1
apter I8 Hypertension r1 r1
Chapter I9 Hyperlipidemia r1 r1
Chapter 20 Chronic Stable Angina and Myocardial Infarction
r1 r1 r1 r1 r1 r1 r1 r1
Chapter 2I Heart Failure r1 r1 r1
Chapter 22 Arrhythmias r1 r1
Chapter 23 Respiratory Infections r1 r1 r1
Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease Chapt
r1 r1 r1 r1 r1 r1 r1 r1
er 25 Gastric, Functional, and Inflammatory Bowel Disorders Chapter
r1 r1 r1 r1 r1 r1 r1 r1 r1
26 Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chapter
r1 r1 r1 r1 r1 r1 r1 r1 r1
27 Liver Diseases
r1 r1
Chapter 28 Urinary Tract Infection r1 r1 r1 r1
Chapter 29 Prostatic Disorders and Erectile Dysfunction Chapt
r1 r1 r1 r1 r1 r1 r1
er 30 Overactive Bladder
r1 r1 r1
Chapter 3I Sexually Transmitted Infections
r1 r1 r1 r1 r
Chapter 32 Osteoarthritis and Gout Chapt
1 r1 r1 r1 r1 r1
er 33 Osteoporosis
r1 r1
Chapter 34 Rheumatoid Arthritis r1 r1 r1 r1
Chapter 35 Headaches r1 r1
Chapter 36 Seizure Disorders r1 r1 r1 r1
Chapter 37 Alzheimer's Disease r1 r1 r1 r 1
Chapter 38 Parkinson's Diseas r1 r1 r1
e
Chapter 39 Major Depressive Disorder and Bipolar Disorders
r1 r1 r1 r1 r1 r1 r1 r1
Chapter 40 Anxiety Disorders r1 r1 r1
Chapter 41 Sleep Disorders r1 r 1 r 1
Chapter 42 Attention Deficit Hyperactivity Disorder
r1 r1 r1 r1 r1 r1
Chapter 43 Substance Use Disorders r1 r1 r1 r1
Chapter 44 Diabetes Mellitus r1 r1 r1
Chapter 45 Thyroid and Parathyroid Disorders
r1 r1 r1 r1 r1
,Chapter 46 Allergies and Allergic Reactions
r1 r1 r1 r1 r1 r1
Chapter 47 Human Immunodeficiency Virus
r1 r1 r1 r1 r1
Chapter 48 Organ Transplantation
r1 r1 r1
Chapter 49 Thromboembolic Disorders Ch
r1 r1 r1 r1
apter 50 Anemias
r1 r1
Chapter 5l Immunizations Chap
r1 r1 r1
ter 52 Smoking Cessation Chapt
r1 r1 r1 r1
er 53 Weight Loss Chapter 54
r1 r1 r1 r1 r1 r1
Contraception
Chapter 55 Menopause
r1 r1
Chapter 56 Vaginitis
r1 r1
, r1 r
r1 r1
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
r1 r1 r1 r1 r1 r1 r1 r1
MULTIPLE CHOICE r1
1. Nurse practitioner prescriptive authority is regulated by:
r1 r1 r1 r1 r1 r1
A. The National Council of State Boards of Nursing
r1 r1 r1 r1 r1 r1 r1
B. The U.S. Drug Enforcement Administration
r1 r1 r1 r1
C. The State Board of Nursing for each state
r1 r1 r1 r1 r1 r1 r1
D. The State Board of Pharmacy
r1 r1 r1 r1
ANS: C r 1 PTS: r 1 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
r1 r1 r1 r1 r1 r1 r1
A. The National Council of State Boards of Nursing
r1 r1 r1 r1 r1 r1 r1
B. The U.S. Drug Enforcement Administration
r1 r1 r1 r1
C. The State Board of Nursing
r1 r1 r1 r1
D. The State Board of Medical Examiners
r1 r1 r1 r1 r1
ANS: D r 1 PTS: r 1 1
3. Clinical judgment in prescribing includes:
r1 r1 r1 r1
A. Factoring in the cost to the patient of the medication prescribed
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
B. Always prescribing the newest medication available for the disease process
r1 r1 r1 r1 r1 r1 r1 r1 r1
C. Handing out drug samples to poor patients
r1 r1 r1 r1 r1 r1
D. Prescribing all generic medications to cut costs r1 r1 r1 r1 r1 r1
ANS: A r 1 PTS: r 1 1
4. Criteria for choosing an effective drug for a disorder include:
r1 r1 r1 r1 r1 r1 r1 r1 r1
A. Asking the patient what drug they think would work best for them
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
B. Consulting nationally recognized guidelines for disease management
r1 r1 r1 r1 r1 r1
C. Prescribing medications that are available as samples before writing a prescription
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
r1 r1 r1 r1 r1 r1 r1 r1
prescribing
ANS: B r 1 PTS: r 1 1
5. Nurse practitioner practice may thrive under health-care reform due to:
r1 r1 r1 r1 r1 r1 r1 r1 r1
A. The demonstrated ability of nurse practitioners to control costs and improve patient
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1 r1 r
outcomes
1
B. The fact that nurse practitioners will be able to practice independently
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
C. The fact that nurse practitioners will have full reimbursement under health-
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
care reform r1
D. The ability to shift accountability for Medicaid to the state level
r1 r1 r1 r1 r1 r1 r1 r1 r1 r1
ANS: A r 1 PTS: r 1 1
